News
Please enjoy the latest industry news aggregated from top Life Sciences sources including BioPharma Dive, FierceBiotech and STAT.
- Hunt for immunotherapy combinations turns up success in kidney cancer
- Stealth Bio’s IPO Raises $78M for Clinical Tests of Mitochondrial Drugs
- The ‘Netflix’ model for hepatitis C drugs is saving Australia a lot of money
- Once a ‘refugee,’ a gene therapy pioneer finds a renewed calling as the field advances
- Bayer Snaps Up Rights to Two Cancer Drugs from Lilly’s $8B Loxo Deal
- FDA grants de novo clearance to Tandem’s plug-and-play insulin pump
- In space, NASA heard astronaut’s immune system scream
- Bill Maris Fund Section 32 Notches Two Wins with Life Science Exits
- With safety data, Bayer could challenge Erleada, Xtandi in prostate cancer: analyst
- STAT Plus: ‘Dancing in the streets’: Health tech leaders emboldened by U.S. plan to free up patient data
- Bharat buys GSK’s Indian vaccine unit to become largest rabies shot producer
- STAT Plus: Medicare would provide national coverage for CAR-T cancer therapies under new proposal
- CRISPR corrects DMD in mice for a year in Sarepta-supported study
- STAT Plus: Up and down the ladder: The latest comings and goings
- Egalet’s 70% price increase shows the buy-and-hike strategy is alive and well